InterMune Inc Share Price
Equities
US45884X1037
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
2014 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Tech/Sci/R&D Officer | 69 | 31/03/02 | |
Carla Fiankan
LAW | General Counsel | - | 31/07/11 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- Stock